The present invention relates to a compound of formula (I) or its pharmaceutically acceptable salts, hydrates or hydrated salts or its polymorphic crystalline structures, racemates, diastereomers or enantiomers, for its use in the prevention and/or treatment of cancer, developmental diseases, neurodegenerative diseases or Trypanomiasis diseases by inhibition of DNA-methyltransferases.
本发明涉及公式(I)的化合物或其药学上可接受的盐,
水合物或
水合盐,多晶形结构,外消旋体,对映体或其利用DNA-甲基转移酶
抑制剂预防和/或治疗癌症,发育性疾病,神经退行性疾病或锥虫病的用途。